|
HBV | Abstract Library |
 |
|
The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
|
|
|
|
|
|
|
|
6. | Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants |
|
Hepatol Commun. 2023 Jul 17;7(8):e0188.doi: 10.1097/HC9.0000000000000188. eCollection 2023 Aug 1.
Alexander J Thompson 1 2, Kathy Jackson 3, Sara Bonanzinga 3, Sam A L Hall 1 2, Simon Hume 1 2, Gareth S Burns 1 2, Vijaya Sundararajan 2 4, Dilip Ratnam 5 6, Miriam T Levy 7, John Lubel 8 9, Amanda J Nicoll 10, Simone I Strasser 11 12, William Sievert 5 6, Paul V Desmond 1, Meng C Ngu 13, Marie Sinclair 14, Christopher Meredith 15, Gail Matthews 16, Peter A Revill 3, Margaret Littlejohn 3, D Scott Bowden 3, Jesse A Canchola 17, Jason Torres 17, Philip Siew 18, Jasmin Lau 17, Benjamin La Brot 17, Alison Kuchta 17, Kumar Visvanathan 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14. | Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance |
|
Vox Sang. 2023 Sep 11. doi: 10.1111/vox.13514. Online ahead of print.
Syria Laperche 1 2, Claire Sauvage 3, Pierre Gallian 1, Saadia Jbilou 1, Elodie Pouchol 1, Jean Yves Py 1, Lila Chabli 1, Pascale Richard 1, Pascal Morel 1 4, Florence Lot 3, Pierre Tiberghien 1 4
|
|
|
|
|
|
|
|
|
18. | Chronic Hepatitis B Finite Treatment: similar and different concerns with new drug classes |
|
Clin Infect Dis. 2023 Aug 26;ciad506. doi: 10.1093/cid/ciad506. Online ahead of print.
Marion G Peters 1, Man-Fung Yuen 2, Norah Terrault 3, John Fry 4, Pietro Lampertico 5, Ed Gane 6, Carey Hwang 7, Luisa M Stamm 8, Mitchell Leus 9, Mala K Maini 10, Patricia Mendez 11, Isabelle Lonjon-Domanec 12, Thomas Berg 13, Su Wang 14, Poonam Mishra 15, Eric Donaldson 15, Stephanie Buchholz 16, Veronica Miller 9, Oliver Lenz 17
|
|
|
|
|
|
|
21. | Enhancing interventions for prevention of mother-to-child- transmission of hepatitis B virus |
|
JHEP Rep. 2023 Apr 24;5(8):100777. doi: 10.1016/j.jhepr.2023.100777.eCollection 2023 Aug.
Philippa C Matthews 1 2 3, Ponsiano Ocama 4, Su Wang 5 6, Manal El-Sayed 7, Anna Turkova 8, Deborah Ford 8, Judith Torimiro 9 10, Ana Cristina Garcia Ferreira 11, Angélica Espinosa Miranda 11, Fernando Pio De La Hoz Restrepo 12, Emmanuel Seremba 4, Robinson Mbu 10, Calvin Q Pan 13, Homie Razavi 14, Geoffrey Dusheiko 15, C Wendy Spearman 16, Saeed Hamid 17
|
|
|
|
|
|
|
|
|
25. | Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance |
|
Clin Gastroenterol Hepatol. 2023 Jul;21(7):1957-1959. doi: 10.1016/j.cgh.2022.06.019.Epub 2022 Jul 16.
Wendy C King 1, Richard K Sterling 2, Amanda S Hinerman 3, Anna S F Lok 4, Gavin A Cloherty 5, Marc G Ghany 6; HBRN HBV NOVELASSAYS GROUP
Collaborators
- HBRN HBV NOVELASSAYS GROUP:
Abdus S Wahed 7, Raymond T Chung 8, Harry L A Janssen 9, Mandana Khalili 10, Daryl T Y Lau 11, William M Lee 12, Mauricio Lisker-Melman 13, Norah Terrault 14
|
|
|
|
|
|
|
28. | Gaps in Prenatal Hepatitis B Screening and Management of HBsAg Positive Pregnant Persons in the U.S., 2015-2020 |
|
Am J Prev Med. 2023 Jul;65(1):52-59. doi: 10.1016/j.amepre.2023.01.041. Epub 2023 Mar 10.
Thi T Hang Pham 1, Nimisha Maria 1, Vivian Cheng 1, Brandon Nguyen 1, Mehlika Toy 1, David Hutton 2, Erin E Conners 3, Noele P Nelson 3, Joshua A Salomon 4, Samuel So 5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
37. | Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B-coinfected adults in care in the United States |
|
J Viral Hepat. 2023 Jul 24. doi: 10.1111/jvh.13874. Online ahead of print.
Nicole D Ferrante 1 2, Michael J Kallan 3, Sophia Sukkestad 4, Maja Kodani 4, Mari M Kitahata 5, Edward R Cachay 6, Debika Bhattacharya 7, Sonya Heath 8, Sonia Napravnik 9, Richard D Moore 10, George Yendewa 11, Kenneth H Mayer 12 13, K Rajender Reddy 1, Tonya Hayden 4, Saleem Kamili 4, Jeffrey N Martin 14, H Nina Kim 5, Vincent Lo Re 3rd 2 15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50. | Validation of a novel point-of-care test for alanine aminotransferase measurement: A pilot cohort study |
|
Liver Int. 2023 May;43(5):989-999. doi: 10.1111/liv.15531. Epub 2023 Feb 16.
Jessica Howell 1 2, Huy Van 1, Minh D Pham 1 3, Rohit Sawhney 2 4 5, Fan Li 1, Purnima Bhat 6, John Lubel 7, William Kemp 7, Stephen Bloom 4 5, Avik Majumdar 8, Geoffrey W McCaughan 8 9, Samuel Hall 2, Timothy Spelman 1, Joseph S Doyle 1 10, Margaret Hellard 1 10, Kumar Visvanathan 2, Alexander Thompson 2, Heidi E Drummer 1 11 12, David Anderson 1
|
|
|
51. | Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™ |
|
J Viral Hepat. 2023 Apr;30(4):335-344. doi: 10.1111/jvh.13800. Epub 2023 Jan 11.
Zobair M Younossi 1 2 3, Ming-Lung Yu 4 5, Yusuf Yilmaz 6 7, Khalid Aida Alswat 8, Maria Buti 9, Marlen Ivon Castellanos Fernandez 10, Georgios Papatheodoridis 11, Saeed S Hamid 12, Mohamed El-Kassas 13, Wah Kheong Chan 14, Ajay K Duseja 15, Stuart C Gordon 16, Yuichiro Eguchi 17, Vasily A Isakov 18, Stuart K Roberts 19 20, Jian-Gao Fan 21, Ashwani K Singal 22, Manuel Romero-Gómez 23, Aijaz Ahmed 24, Janus Ong 25, Brian P Lam 1 2 3, Issah Younossi 26, Fatema Nader 26, Andrei Racila 26, Maria Stepanova 1 2 3 26, Saleh Alqahtani 26 27
|
|
|
52. | Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial |
|
Am J Gastroenterol. 2023 May 5. doi: 10.14309/ajg.0000000000002176. Online ahead of print.
Jordan J Feld 1 2, Abdus S Wahed 3 4, Michael Fried 5, Marc G Ghany 6, Adrian M Di Bisceglie 7, Robert P Perrillo 8, Mandana Khalili 9, Xue Yang 3, Steven H Belle 3 4, Harry L A Janssen 1 2, Norah Terrault 10, Anna S Lok 11; Hepatitis B Research Network (HBRN)
|
|
|
53. | Pathway to global elimination of hepatitis B: HBV cure is just the first step |
|
Hepatology. 2023 May 1. doi: 10.1097/HEP.0000000000000430. Online ahead of print.
Jessica Howell 1 2 3 4, Chris Seaman 1 4, Jack Wallace 1, Yinzong Xiao 1, Nick Scott 1, Jane Davies 5, Teresa de Santis 5, Danjuma Adda 6, Manal El-Sayed 7, Jordan J Feld 8, Edward Gane 9, Karine Lacombe 10, Olufunmilayo Lesi 11, Rosmawati Mohamed 12, Marcelo Silva 13, Thomas Tu 14 15, Peter Revill 16, Margaret E Hellard 1 4 17 18
|
|
|
54. | Use of HBV RNA and hepatitis B core-related antigen to predict change in serological status and disease activity in CHB |
|
Hepatology. 2023 Apr 20. doi: 10.1097/HEP.0000000000000413. Online ahead of print.
Marc G Ghany 1, Wendy C King 2, Amanda S Hinerman 3, Anna Sf Lok 4, Mauricio Lisker-Melman 5, Raymond T Chung 6, Norah Terrault 7, Harry L A Janssen 8, Mandana Khalili 9, William M Lee 10, Daryl T Y Lau 11, Gavin A Cloherty 12, Richard K Sterling 13
|
|
|
|
|
|
|
|
|
58. | Hepatitis B virus infection in general practice across England: An analysis of the Royal College of General Practitioners Research and Surveillance Centre real-world database |
|
J Infect. 2023 May;86(5):476-485. doi: 10.1016/j.jinf.2023.03.001. Epub 2023 Mar 9.
Anna Maria Geretti 1, Harrison Austin 2, Giovanni Villa 3, Colette Smith 4, Caroline Sabin 5, Ruby Tsang 6, Julian Sherlock 6, Filipa Ferreira 6, Rachel Byford 6, Bernardo Meza-Torres 6, Martin Whyte 6, Simon de Lusignan 6
|
|
|
59. | Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease |
|
Vaccine. 2023 May 11;41(20):3224-3232. doi: 10.1016/j.vaccine.2023.04.028.Epub 2023 Apr 19.
Matthias Girndt 1, Patricia Houser 2, Roberto Manllo-Karim 3, John E Ervin 4, Chaim Charytan 5, Stephen Chow 6, Margarita Symonian-Silver 7, Lawrence Lehrner 8, Douglas Linfert 9, Douglas Shemin 10, Ann Michelsen 11, Fang Xie 12, Robert S Janssen 13
|
|
|
|
|
61. | Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis |
|
Hepatology. 2023 Apr 1;77(4):1348-1365. doi: 10.1002/hep.32731. Epub 2022 Sep 16.
Dimitri Loureiro 1 2, Issam Tout 1 2, Stéphanie Narguet 1 2, Cheikh Mohamed Bed 1 2, Morgane Roinard 1 2, Ahmad Sleiman 1 2, Nathalie Boyer 1 2, Nathalie Pons-Kerjean 3, Corinne Castelnau 1 2, Nathalie Giuly 1 2, Dorothy Tonui 1 2, Vassili Soumelis 4 5, Jamel El Benna 1, Patrick Soussan 6, Richard Moreau 1 2, Valérie Paradis 1 2, Abdellah Mansouri 1 2, Tarik Asselah 1 2
|
|
|
|
|
63. | Hepatitis B in Heart Transplant Donors and Recipients: A Systematic Review and Meta-Analysis |
|
Surg Res. 2023 Mar;283:1078-1090. doi: 10.1016/j.jss.2022.10.078.Epub 2022 Dec 15.
Colin C Yost 1, Diana C Jimenez 1, Matthew P Weber 1, Elizabeth J Maynes 1, Katherine A Belden 2, Vakhtang Tchantchaleishvili 1, H Todd Massey 1, David A Sass 3, J Eduardo Rame 4, John J Zurlo 2, Nana Aburjania 5
|
|
|
64. | Transplanting hepatitis B surface antigen-positive livers in the United States: outcomes and opportunities |
|
Am J Transplant. 2023 Apr 26;S1600-6135(23)00428-8. doi: 10.1016/j.ajt.2023.04.024.Online ahead of print.
Anshul Bhatnagar 1, Sameer Prakash 2, Peter Lymberopoulos 3, Cameron Goff 1, Anjiya Shaikh 4, Donghee Kim 5, Aijaz Ahmed 5, Carl Berg 6, Susanna Naggie 7, Fasiha Kanwal 8, George Cholankeril 9, Tzu-Hao Lee 10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
72. | Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care center |
|
United European Gastroenterol J. 2023 Apr;11(3):293-304. doi: 10.1002/ueg2.12376.Epub 2023 Mar 25.
Mathias Jachs 1, Raphael Sauberer 1, Alexander Stiegler 1, Anton Dechêne 1, Raphael Tazreiter 1, Lukas Hartl 1, David Bauer 1, Lorenz Balcar 1, Robert Strassl 2, Mattias Mandorfer 1, Michael Trauner 1, Petra Munda 1, Peter Ferenci 1, Thomas Reiberger 1
|
|
|
73. | A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B |
|
J Hepatol. 2023 May;78(5):926-936.doi: 10.1016/j.jhep.2022.12.018. Epub 2023 Mar 28.
Florian van Bömmel 1, Kerstin Stein 2, Renate Heyne 3, Jörg Petersen 4, Peter Buggisch 4, Christoph Berg 5, Stefan Zeuzem 6, Andreas Stallmach 7, Martin Sprinzl 8, Eckart Schott 9, Anita Pathil-Warth 10, Ulrike von Arnim 11, Verena Keitel 12, Jürgen Lohmeyer 13, Karl-Georg Simon 14, Christian Trautwein 15, Andreas Trein 16, Dietrich Hüppe 17, Markus Cornberg 18, Frank Lammert 19, Patrick Ingiliz 20, Reinhart Zachoval 21, Holger Hinrichsen 22, Alexander Zipprich 23, Hartmuth Klinker 24, Julian Schulze Zur Wiesch 25, Anett Schmiedeknecht 26, Oana Brosteanu 26, Thomas Berg 27
|
|
|
|
|
|
|
76. | Hepatitis B virus and hepatitis D virus infection in women with or at risk for HIV infection in the United States |
|
Front Med (Lausanne). 2023 Mar 2;10:1070420. doi: 10.3389/fmed.2023.1070420.eCollection 2023.
Ilona Argirion 1, Parag Mahale 1, Ruth M Pfeiffer 2, Ping Liu 3, Adaora A Adimora 4, Matthew J Akiyama 5 6, Hector H Bolivar 7, Audrey French 8 9, Michael Plankey 10, Jennifer C Price 11, Aadia Rana 12, Anandi Sheth 13 14, Jill Koshiol 1, Eric C Seaberg 15, Mark H Kuniholm 16, Jeffrey Glenn 3, Thomas R O'Brien 1
|
|
|
|
|
|
|
|
|
80. | Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial |
|
Sex Transm Infect. 2023 Mar;99(2):140-142.doi: 10.1136/sextrans-2022-055634. Epub 2022 Dec 8.
Paul Le Turnier 1 2 3, Isabelle Charreau 4, Audrey Gabassi 5 6, Diane Carette 4, Laurent Cotte 7, Gilles Pialoux 8, Cécile Tremblay 9, Bruno Spire 10, Marie-Laure Chaix 5 6, Laurence Meyer 4 11, Catherine Capitant 4, Constance Delaugerre 5 6, François Raffi # 12 2, Jean-Michel Molina # 6 13; ANRS IPERGAY study group
|
|
|
|
|
|
|
|
|
84. | Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination |
|
Int J Infect Dis. 2023 Apr;129:266-273. doi: 10.1016/j.ijid.2023.02.006.Epub 2023 Feb 13.
Giuseppina Brancaccio 1, Barbara Coco 2, Alessandra Nardi 3, Maria Giovanna Quaranta 4, Maria Elena Tosti 4, Luigina Ferrigno 4, Irene Cacciola 5, Vincenzo Messina 6, Luchino Chessa 7, Filomena Morisco 8, Michele Milella 9, Francesco Barbaro 10, Alessia Ciancio 11, Francesco Paolo Russo 12, Nicola Coppola 13, Pierluigi Blanc 14, Ernesto Claar 15, Gabriella Verucchi 16, Massimo Puoti 17, Anna Linda Zignego 18, Liliana Chemello 19, Salvatore Madonia 20, Stefano Fagiuoli 21, Alfredo Marzano 22, Carlo Ferrari 23, Pietro Lampertico 24, Vito Di Marco 25, Antonio Craxì 26, Teresa Antonia Santantonio 27, Giovanni Raimondo 5, Maurizia R Brunetto 2, Giovanni Battista Gaeta 28, Loreta A Kondili 29; PITER collaborating investigators
|
|
|
85. | Hepatitis B virus-infection related cryoglobulinemic vasculitis. Clinical manifestations and the effect of antiviral therapy: A review of the literature |
|
Front Oncol. 2023 Feb 7;13:1095780. doi: 10.3389/fonc.2023.1095780.eCollection 2023.
Cesare Mazzaro 1, Riccardo Bomben 1, Marcella Visentini 2, Laura Gragnani 3, Luca Quartuccio 4, Francesco Saccardo 5, Marco Sebastiani 6, Davide Filippini 7, Gianfranco Lauletta 8, Giuseppe Monti 5, Valter Gattei 1
|
|
|
|
|
|
|
|
|
|
|
90. | Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection |
|
Gut. 2023 Jan 25;gutjnl-2022-328041. doi: 10.1136/gutjnl-2022-328041. Online ahead of print.
Harry L A Janssen 1 2, Jinlin Hou 3, Tarik Asselah 4, Henry L Y Chan 5, Fabien Zoulim 6, Yasuhito Tanaka 7, Ewa Janczewska 8, Ronald G Nahass 9, Stefan Bourgeois 10, Maria Buti 11, Pietro Lampertico 12 13, Oliver Lenz 14, Thierry Verbinnen 14, Joris Vandenbossche 14, Willem Talloen 14, Ronald Kalmeijer 15, Maria Beumont 15, Michael Biermer 16, Umesh Shukla 15
|
|
|
|
|
92. | Liver Complications in Untreated Treatment-Ineligible versus Treated Treatment-Eligible Patients with Hepatitis B |
|
Dig Dis. 2023;41(1):115-123. doi: 10.1159/000526933. Epub 2022 Sep 7.
Daniel Q Huang 1 2, Dong Hyun Lee 3 4, Michael H Le 4, An Le 4, Yee Hui Yeo 4, Huy N Trinh 5, Mimi Chung 6, Vy Nguyen 4, Tiffani Johnson 7, Jian Q Zhang 8, Clifford Wong 9, Christopher Wong 9, Jiayi Li 10, Ramsey Cheung 4 11, Mindie H Nguyen 4
|
|
|
93. | Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure |
|
Gut. 2023 Jan 27;gutjnl-2022-328380. doi: 10.1136/gutjnl-2022-328380. Online ahead of print.
Lena Allweiss 1 2, Barbara Testoni 3 4, Mei Yu 5, Julie Lucifora 3 4 6, Chunkyu Ko 7 8, Bingqian Qu 9 10, Marc Lütgehetmann 2 11, Haitao Guo 12 13, Stephan Urban 2 9, Simon P Fletcher 5, Ulrike Protzer 2 7, Massimo Levrero 3 4, Fabien Zoulim 14 4, Maura Dandri 15 2
|
|
|
|
|
|
|
|
|
97. | Early vs late histological confirmation of coeliac disease in children with new-onset type 1 diabetes |
|
Diabetologia. 2022 Jul;65(7):1108-1118. doi: 10.1007/s00125-022-05701-w. Epub 2022 Apr 30.
Clemens Kamrath 1, Sascha R Tittel 2 3, Desiree Dunstheimer 4, Elke Fröhlich-Reiterer 5, Markus Freff 6, Claudia Böttcher 7, Nadine Scheffler 8, Stefanie Lenze 9, Elke Gericke 10, Susanne Thiele 11, Reinhard W Holl 2 3
|
|
|
|
|
|
|
|
|
|
|
102. | Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways |
|
J Infect Dis. 2022 Dec 28;227(1):123-132. doi: 10.1093/infdis/jiac375.
Samuel A L Hall 1 2, Gareth S Burns 1 2, Benjamin J Mooney 2, Rosemary Millen 2, Rachel Morris 2, Sara Vogrin 2, Vijaya Sundararajan 3, Dilip Ratnam 4, Miriam T Levy 5, John S Lubel 6 7, Amanda J Nicoll 8, Simone I Strasser 9 10, William Sievert 4 11, Paul V Desmond 1, Meng C Ngu 12, Peter Angus 13 14, Marie Sinclair 13, Christopher Meredith 15, Gail Matthews 16, Peter A Revill 17, Kathy Jackson 17, Margaret Littlejohn 17, Scott Bowden 17, Stephen A Locarnini 17, Alexander J Thompson 1 2, Kumar Visvanathan 1 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
109. | Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection |
|
Antimicrob Agents Chemother. 2022 Dec 15;e0134822. doi: 10.1128/aac.01348-22.Online ahead of print.
Dara Burdette 1, Anastasia Hyrina 1, Zhijuan Song 1, Rudolf K Beran 1, Tara Cheung 1, Sarah Gilmore 1, Tetsuya Kobayashi 1, Li Li 1, Yang Liu 1, Anita Niedziela-Majka 1, Jonathan Medley 1, Upasana Mehra 1, Philip Morganelli 1, Nikolai Novikov 1, Congrong Niu 1, Danny Tam 1, Jennifer Tang 1, Jianhong Wang 1, Qin Yue 1, Simon P Fletcher 1, Meghan M Holdorf 1, William E Delaney 4th 1, Becket Feierbach 1, Scott Lazerwith 1
|
|
|
|
|
|
|
|
|
113. | EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B |
|
Antivir Ther. 2022 Dec;27(6):13596535221127848. doi: 10.1177/13596535221127848.
Jordan J Feld 1, Eric Lawitz 2, Tuan Nguyen 3, Jacob Lalezari 4, Tarek Hassanein 5, Paul Martin 6, Steven-Huy Han 7, Douglas Dieterich 8, Jeanne-Marie Giard 9, Guy De La Rosa 10, Alaa Ahmad 10, Ed Luo 10, Annie L Conery 10, Nathalie Adda 10
|
|
|
|
|
115. | Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B |
|
Aliment Pharmacol Ther. 2022 Nov 25. doi: 10.1111/apt.17299. Online ahead of print.
Josef Wagner 1 2, Lilly Yuen 1 3, Margaret Littlejohn 1, Vitina Sozzi 1, Kathy Jackson 1, Ross Martin 4, Thomas Aeschbacher 4, Vithika Suri 4, Susanna K Tan 4, Becket Feierbach 4, Anuj Gaggar 4, Patrick Marcellin 5, Maria Buti Ferret 6, Harry L A Janssen 7, Ed Gane 8, Niamh Meagher 3, David J Price 3 9, Darren Wong 1 10, Alexander T Thompson 10, Peter A Revill 1 3 11
|
|
|
|
|
117. | Universal testing for hepatitis B and hepatitis C in the emergency department: a cost-effectiveness and budget impact analysis of two urban hospitals in the United Kingdom |
|
Cost Eff Resour Alloc. 2022 Nov 14;20(1):60. doi: 10.1186/s12962-022-00388-7.
Jack Williams 1 2, Peter Vickerman 3 4, Elizabeth Smout 5, Emma E Page 6, Khine Phyu 6, Mark Aldersley 6, Gaia Nebbia 7, Sam Douthwaite 7, Laura Hunter 8, Murad Ruf 9, Alec Miners 10 11
|
|
|
|
|
|
|
120. | Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection |
|
N Engl J Med. 2022 Nov 24;387(21):1957-1968. doi: 10.1056/NEJMoa2210027.Epub 2022 Nov 8.
Man-Fung Yuen 1, Seng-Gee Lim 1, Robert Plesniak 1, Keiji Tsuji 1, Harry L A Janssen 1, Cristina Pojoga 1, Adrian Gadano 1, Corneliu P Popescu 1, Tatyana Stepanova 1, Tarik Asselah 1, Gheorghe Diaconescu 1, Hyung Joon Yim 1, Jeong Heo 1, Ewa Janczewska 1, Alexander Wong 1, Nevin Idriz 1, Michio Imamura 1, Giuliano Rizzardini 1, Koichi Takaguchi 1, Pietro Andreone 1, Manuela Arbune 1, Jinlin Hou 1, Sung Jae Park 1, Andrei Vata 1, Jennifer Cremer 1, Robert Elston 1, Tamara Lukic 1, Geoff Quinn 1, Lauren Maynard 1, Stuart Kendrick 1, Helene Plein 1, Fiona Campbell 1, Melanie Paff 1, Dickens Theodore 1, B-Clear Study Group
|
|
|
|
|
|
|
|
|
124. | Health Within Reach-a Patient-Centered Intervention to Increase Hepatitis B Screening Among Asian Americans: a Randomized Clinical Trial |
|
J Gen Intern Med. 2022 Oct;37(13):3242-3250.doi: 10.1007/s11606-021-07232-3. Epub 2022 Jan 6.
Mandana Khalili 1, Nicole J Kim 2, Janice Y Tsoh 3, Judith M E Walsh 4, L Elizabeth Goldman 4, Ginny Gildengorin 4, Ching Wong 4, Mi T Tran 4, Edgar Yu 3, Michael Thanh Sharp 4, Vivian H LeTran 4, Vi-Van Nguyen 4, Tung T Nguyen 4
|
|
|
125. | Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus |
|
Clin Res Hepatol Gastroenterol. 2022 Oct;46(8):101773.doi: 10.1016/j.clinre.2021.101773. Epub 2021 Jul 28.
Vincent Leroy 1, Stéphane Chevaliez 2, Marie Decraecker 3, Dominique Roulot 4, Jean Nana 5, Tarik Asselah 6, Xavier Causse 7, David Durantel 8, Vincent Thibaut 9, Nathalie Ganne-Carrié 4, Christophe Bureau 10, Victor de Lédinghen 3, Marc Bourlière 11
|
|
|
|
|
|
|
128. | Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study |
|
Hum Vaccin Immunother. 2022 Oct 21;2136912. doi: 10.1080/21645515.2022.2136912.Online ahead of print.
Matthias Girndt 1, Manfred Plüer 2, Frank Dellanna 3, Ann K Michelsen 4, Joachim Beige 5, Kai Toussaint 6, Hubert J Wehweck 7, Michael Koch 8, Syrus Hafezi Rachti 9, Justus Faust 10, Hans-Peter Bosselmann 11, Oliver Witzke 12, Robert S Janssen 13, HBV-18 Study Investigators 14
|
|
|
|
|
|
|
|
|
|
|
|
|
134. | Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial |
|
Lancet Infect Dis. 2022 Sep 13;S1473-3099(22)00318-8. doi: 10.1016/S1473-3099(22)00318-8.Online ahead of print.
Heiner Wedemeyer 1, Katrin Schöneweis 2, Pavel Bogomolov 3, Antje Blank 4, Natalia Voronkova 5, Tatiana Stepanova 6, Olga Sagalova 7, Vladimir Chulanov 8, Marina Osipenko 9, Viacheslav Morozov 10, Natalia Geyvandova 11, Snezhana Sleptsova 12, Igor G Bakulin 13, Ilsiyar Khaertynova 14, Marina Rusanova 15, Anita Pathil 16, Uta Merle 17, Birgit Bremer 18, Lena Allweiss 19, Florian A Lempp 20, Kerstin Port 18, Mathias Haag 21, Matthias Schwab 22, Julian Schulze Zur Wiesch 19, Markus Cornberg 18, Walter E Haefeli 4, Maura Dandri 19, Alexander Alexandrov 23, Stephan Urban 24
|
|
|
|
|
|
|
|
|
138. | Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in Denmark |
|
J Viral Hepat. 2022 Sep;29(9):727-736. doi: 10.1111/jvh.13713. Epub 2022 Jun 9.
Signe Bollerup 1, Sofie Hallager 1, Frederik Engsig 1, Amanda Mocroft 2 3, Henrik Krarup 4 5, Lone G Madsen 6 7, Peter Thielsen 8, Ulla Balslev 9, Helene Mens 10, Toke S Barfod 11, Mette R Clausen 12, Lise Hobolth 13, Alex L Laursen 14, Britta Tarp 15, Birgit T Roege 16, Jesper B Hansen 5, Lone Mygind 17, Peer B Christensen 18 19, Jan Gerstoft 7 20, Nina Weis 1 7
|
|
|
|
|
|
|
|
|
|
|
143. | Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study |
|
Clin Epidemiol. 2022 Jul 18;14:879-888. doi: 10.2147/CLEP.S361910. eCollection 2022.
Frederik Faergemann Lau 1, Signe Bollerup 1, Frederik Engsig 1, Henrik Krarup 2, Lone Hagens Mygind 3, Jesper Bach Hansen 3, Lone Galmstrup Madsen 4 5, Peter Thielsen 6, Ulla Balslev 7, Lars Nørregaard Nielsen 8, Toke S Barfod 9, Mette Rye Clausen 10, Lise Hobolth 11, Alex Lund Laursen 12, Britta Tarp 13, Birgit T Roege 14, Jan Gerstoft 15, Peer Brehm Christensen 16 17, Nina Weis 1 5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
152. | Routine screening of emergency admissions at risk of chronic hepatitis (SEARCH) identifies and links hepatitis B cases to care |
|
Liver Int. 2022 Sep 1. doi: 10.1111/liv.15414. Online ahead of print.
Rachael Jacob 1 2, David S Prince 1 2, Joseph L Pipicella 1 3, Angela Nguyen 1 4, Melissa Bagatella 1, Frank Alvaro 1 5, Michael Maley 1 3 5, Hong Foo 1 5, Paul Middleton 1 2 6, Tahrima Kayes 1, Julia DiGirolamo 1, Scott A Davison 1 2, Miriam T Levy 1 2 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
159. | The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study |
|
HIV Med. 2022 Jul;23(6):585-598. doi: 10.1111/hiv.13210. Epub 2021 Dec 9.
Amanda Mocroft 1 2, Jose M Miro 3, Gilles Wandeler 4, Josep M Llibre 5, Anders Boyd 6 7, Kathrin van Bremen 8, Marek Beniowski 9, Julia Mikhalik 10, Matthias Cavassini 11, Fernando Maltez 12, Claudine Duvivier 13 14 15 16, Caterina Uberti Foppa 17, Brygida Knysz 18, Elzbieta Bakowska 19, Elena Kuzovatova 20, Pere Domingo 21, Alexandra Zagalo 22, Jean-Paul Viard 23, Olaf Degen 24, Ana Milinkovic 25, Thomas Benfield 26, Lars Peters 1, EuroSIDA study group
|
|
|
|
|
161. | Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection |
|
Clin Gastroenterol Hepatol. 2022 Jul 16;S1542-3565(22)00653-X.doi: 10.1016/j.cgh.2022.06.015. Online ahead of print.
Jordan J Feld 1, Wendy C King 2, Marc G Ghany 3, Kyong-Mi Chang 4, Norah Terrault 5, Robert P Perrillo 6, Mandana Khalili 7, Amanda S Hinerman 2, Harry LA Janssen 8, Anna S Lok 9, Hepatitis B Research Network (HBRN)
|
|
|
|
|
|
|
|
|
|
|
166. | Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance |
|
Clin Gastroenterol Hepatol. 2022 Jul 16;S1542-3565(22)00660-7.doi: 10.1016/j.cgh.2022.06.019. Online ahead of print.
Wendy C King 1, Richard K Sterling 2, Amanda S Hinerman 3, Anna S F Lok 4, Gavin A Cloherty 5, Marc G Ghany 6, HBRN HBV Novel Assays Group (Corporate authorship); Abdus S Wahed 7, Raymond T Chung 8, Harry L A Janssen 9, Mandana Khalili 10, Daryl T Y Lau 11, William M Lee 12, Mauricio Lisker-Melman 13, Norah Terrault 14
|
|
|
|
|
168. | Predicting hepatitis B e Antigen seroconversion after pregnancy-The SydPregScore |
|
Liver Int. 2022 Jul 21. doi: 10.1111/liv.15372. Online ahead of print.
Cynthuja Thilakanathan 1 2, Tahrima Kayes 1, Julia Di Girolamo 1, Vi Nguyen 2, Anne Glass 1, Sicha Manandhar 1, Joseph Lawler 3, Chris Meredith 3, Michael Maley 2 4, Andrew Lloyd 5, Miriam T Levy 1 2
|
|
|
|
|
|
|
171. | Hepatitis B Virus Reactivation Associated with New Classes of Immunosuppressants and Immunomodulators: A Systematic Review, Meta-analysis, and Expert Opinion |
|
J Hepatol. 2022 Jul 15;S0168-8278(22)02935-X. doi: 10.1016/j.jhep.2022.07.003.Online ahead of print.
George V Papatheodoridis 1, Vasileios Lekakis 1, Thodoris Voulgaris 2, Pietro Lampertico 3, Thomas Berg 4, Henry L Y Chan 5, Jia-Horng Kao 6, Norah Terrault 7, Anna S Lok 8, K Rajender Reddy 9
|
|
|
172. | Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease |
|
Pediatr Qual Saf. 2022 Jun 23;7(4):e570. doi: 10.1097/pq9.0000000000000570.eCollection 2022 Jul-Aug.
Megan Megan McNicol 1, Amy Donegan 2, Kate Hawa 3, Angelique E Boutzoukas 3, Barb Drobnic 2, Melanie Oates 2, Maudie Orraca-Tetteh 2, Hilary K Michel 2, Ross M Maltz 2, Jennifer L Dotson 2, Don Buckingham 4, Brendan Boyle 2, Monica I Ardura 5
|
|
|
173. | Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection |
|
J Hepatol. 2022 Jun 10;S0168-8278(22)00348-8. doi: 10.1016/j.jhep.2022.05.027.Online ahead of print.
Mark S Sulkowski 1, Kosh Agarwal 2, Xiaoli Ma 3, Tuan T Nguyen 4, Eugene R Schiff 5, Hie-Won L Hann 6, Douglas T Dieterich 7, Ronald G Nahass 8, James S Park 9, Sing Chan 10, Steven-Huy B Han 11, Edward J Gane 12, Michael Bennett 13, Katia Alves 14, Marc Evanchik 14, Ran Yan 14, Qi Huang 14, Uri Lopatin 14, Richard Colonno 14, Julie Ma 14, Steven J Knox 14, Luisa M Stamm 14, Maurizio Bonacini 15, Ira M Jacobson 9, Walid S Ayoub 16, Frank Weilert 17, Natarajan Ravendhran 18, Alnoor Ramji 19, Paul Yien Kwo 20, Magdy Elkhashab 21, Tarek Hassanein 22, Ho S Bae 23, Jacob P Lalezari 15, Scott K Fung 24, Man-Fung Yuen 25
|
|
|
|
|
175. | Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection |
|
Aliment Pharmacol Ther. 2022 Aug;56(3):510-518. doi: 10.1111/apt.17040. Epub 2022 May 22.
Tahrima Kayes 1 2, Harry Crane 1 2, Allison Symonds 3, Julie Dumond 3, Mackenzie Cottrell 3, Julia Di Girolamo 1 2, Sicha Manandhar 1 2, Tien Huey Lim 4, Edward Gane 5, Angela Kashuba 3, Miriam T Levy 1 2 6
|
|
|
176. | Updated U.S. Public Health Service Guideline for Testing of Transplant Candidates Aged <12 Years for Infection with HIV, Hepatitis B Virus, and Hepatitis C Virus - United States, 2022 |
|
MMWR Morb Mortal Wkly Rep. 2022 Jul 1;71(26):844-846. doi: 10.15585/mmwr.mm7126a2.
Rebecca J Free, Marilyn E Levi, James S Bowman, Danae Bixler, John T Brooks, Kate Buchacz, Anne Moorman, James Berger, Sridhar V Basavaraju
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
190. | Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis |
|
JAMA Netw Open. 2022 Jun 1;5(6):e2219407.doi: 10.1001/jamanetworkopen.2022.19407.
Darren Jun Hao Tan 1, Cheng Han Ng 1, Phoebe Wen Lin Tay 1, Nicholas Syn 1, Mark D Muthiah 1 2 3, Wen Hui Lim 1, Ansel Shao Pin Tang 1, Kai En Lim 1, Grace En Hui Lim 4, Nobuharu Tamaki 5, Beom Kyung Kim 5 6 7, Margaret Li Peng Teng 1 2 3, James Fung 8, Rohit Loomba 9, Mindie H Nguyen 10, Daniel Q Huang 1 2 3 9
|
|
|
|
|
|
|
|
|
194. | Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels |
|
Aliment Pharmacol Ther. 2022 May 6. doi: 10.1111/apt.16968. Online ahead of print.
Samuel A L Hall 1 2, Gareth S Burns 1 2, Despina Anagnostou 1, Sara Vogrin 2, Vijaya Sundararajan 2 3, Dilip Ratnam 4 5, Miriam T Levy 6, John S Lubel 7 8, Amanda J Nicoll 9, Simone I Strasser 10 11, William Sievert 4 5, Paul V Desmond 1, Meng C Ngu 12, Peter Angus 13 14, Marie Sinclair 13, Christopher Meredith 15, Gail Matthews 16, Peter A Revill 17, Kathy Jackson 17, Margaret Littlejohn 17, D Scott Bowden 17, Stephen A Locarnini 17, Kumar Visvanathan 1 2, Alexander J Thompson 1 2
|
|
|
|
|
|
|
|
|
198. | Australian consensus recommendations for the management of hepatitis B |
|
Med J Aust. 2022 May 16;216(9):478-486. doi: 10.5694/mja2.51430. Epub 2022 Mar 6.
John S Lubel 1 2, Simone I Strasser 3 4, Alexander J Thompson 5 6, Benjamin C Cowie 7 8, Jennifer MacLachlan 7, Nicole L Allard 6 7, Jacinta Holmes 5 6, William W Kemp 1, Avik Majumdar 3, David Iser 5, Jess Howell 2 6 9, Gail V Matthews 10 11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | | | | |